SCHEMBL4591173

SCHEMBL4591173

CCCCC(N)C(=O)ON1C(=O)CCC1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP7 Q9UHL4 5/20 0.38
SLC15A1 P46059 1/20 0.38
METAP1 P53582 1/20 0.38
DPP4 P27487 4/20 0.38
DPP8 Q6V1X1 4/20 0.36
DPP9 Q86TI2 4/20 0.36
FAP Q12884 1/20 0.36
SLC1A3 P43003 1/20 0.36
SLC1A2 P43004 1/20 0.36
SLC1A1 P43005 1/20 0.36
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
DDAH1 O94760 1/20 0.34
CHEK1 O14757 1/20 0.33
ERAP2 Q6P179 2/20 0.33
LNPEP Q9UIQ6 2/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
KDM4E B2RXH2 1/20 0.33
NOD1 Q9Y239 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9504953 1.00 DPP7 (0.38) DPP7SLC15A1METAP1DPP4DPP8
SCHEMBL7257373 0.86 DPP7 (0.38) DPP7DPP4DPP8DPP9FAP
SCHEMBL7257377 0.86 DPP7 (0.38) DPP7DPP4DPP8DPP9FAP
SCHEMBL7257370 0.86 DPP7 (0.38) DPP7DPP4DPP8DPP9FAP
SCHEMBL1273914 0.84 GSR (0.44) DPP7DPP4DPP8DPP9FAP
SCHEMBL7776987 0.84 GSR (0.44) DPP7DPP4DPP8DPP9FAP
SCHEMBL23802513 0.84 CA2 (0.43) SLC1A3SLC1A2SLC1A1CA1CA2
SCHEMBL13959349 0.84 DPP7 (0.41) DPP7SMN1; SMN2NOD1
SCHEMBL18540901 0.83 CA1 (0.37) CA1CA2KMT2ASMN1; SMN2KDM4E
SCHEMBL4867939 0.83 ZDHHC7 (0.47) CA1CA2KMT2ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160356786-A1 Novel Isobaric Tandem Mass Tags for Quantitative Proteomics and Peptidomics WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2016-12-08 US disclosed
EP-1874738-A1 PYRIMIDINES REACTING WITH O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE Covalys Biosciences AG (CH) 2008-01-09 EP disclosed
WO-2006114409-A9 PYRIMIDINES REACTING WITH O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE COVALYS BIOSCIENCES AG (CH) 2007-10-18 WO disclosed
WO-2006114409-A1 PYRIMIDINES REACTING WITH O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE COVALYS BIOSCIENCES AG (CH) 2006-11-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160356786-A1 Novel Isobaric Tandem Mass Tags for Quantitative Proteomics and Peptidomics SRMS, TMT1A, PTMS DPP7 1345/4885SLC15A1 3177/4885METAP1 303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.